About Nibec
Nibec is a publicly listed company based in Jecheon-si (South Korea) founded in 2004. Peptide-based products for tissue regeneration are developed and provided. The company has 96 employees. Its focus areas include Life Sciences, Dental Disorders, Medical Devices and Therapeutic Devices.
Company details
Nibec was founded in 2004 in South Korea. Medical and pharmaceutical products are offered, including oral care items, biomaterials for tissue regeneration, peptide-based bio fusion solutions, and cosmetics. Technologies such as peptide discovery methods, drug delivery systems, and tissue regenerative approaches are employed. FDA 510(k) clearance has been secured for several products, supporting applications in healthcare and related sectors.
- Headquarters Jecheon-si, South Korea
- Employees 96
- Stage Public
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website nibec.co.kr
- Legal Name Nibec Co., Ltd.
- Annual Revenue$22.66 M (USD)33.27as on Dec 31, 2025
- Net Profit$3.21 M (USD)as on Dec 31, 2025
- EBITDA$4.96 M (USD)as on Dec 31, 2025
- Latest Funding Round$5.22M (USD), Post-IPO
Mar 2016
- Employee Count96
Funding Insights of Nibec
- Total Rounds 1
- Last Round Post-IPO — $5.22M
- First Round $5.22M
(Mar 2016)
All 1 funding rounds of Nibec with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2016 | $5.22M | Post-IPO | – | – | – |
IPO & Listings of Nibec
Nibec is a publicly listed company on the KRX with ticker symbol 138610 in South Korea, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date13 Jul 2011
- Listed onKRX: 138610
- Listed entityNIBEC Co., Ltd.
- Exchange sectorHealth technology
- ISINKR7138610001
- Share price14,450.00 KRW (-1.57% on the day) · 2026-10-14
- Market capitalisation166,879,202,461.00 KRW
- Price to earnings150.0
- EPS (diluted, trailing year)-2.22 KRW
- Volume (last session)21,202
Financials of Nibec
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 32.72B KRW | 4.64B KRW | 7.17B KRW |
| 2024 | 24.55B KRW | -9.33B KRW | -1.68B KRW |
| 2023 | 15.70B KRW | -6.28B KRW | 1.15B KRW |
| 2022 | 21.67B KRW | -3.79B KRW | 3.75B KRW |
| 2021 | 13.63B KRW | -5.74B KRW | 460.5M KRW |
Detailed financial statements for Nibec
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Nibec
3 dated milestones of Nibec across 12 years, from founding to its latest funding, stage changes and deals.
- Founded Nibec is founded.
- IPO Lists on the stock exchange (IPO).
- Funding First funding round of $5.2M.
Web traffic of Nibec
The website of Nibec (nibec.co.kr) receives about 4.4K visits a month.
- Monthly visits4.4K
▼ 16% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Nibec
Complete news archive for Nibec
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nibec
Nibec was founded in 2004 and raised its 1st funding round 12 years after it was founded.
Nibec is headquartered in Jecheon-si, South Korea. It is registered at Jecheon-si, Chungcheongbuk-do, South Korea.
Nibec has 96 employees.
Annual revenue of Nibec is $22.66M as on Dec 31, 2025.
Nibec was founded in 2004 in South Korea. Medical and pharmaceutical products are offered, including oral care items, biomaterials for tissue regeneration, peptide-based bio fusion solutions, and cosmetics. Technologies such as peptide discovery methods, drug delivery systems, and tissue regenerative approaches are employed. FDA 510(k) clearance has been secured for several products, supporting applications in healthcare and related sectors.
Yes, Nibec is publicly traded on KRX under the ticker symbol 138610.